Indian hospitals are running out of two life-saving cancer drugs as the war in Iran continues to disrupt the supply of raw materials.
Stocks of cisplatin and carboplatin, two of the most widely used chemotherapy drugs in the country, have begun running dry over the last three weeks, doctors and pharmaceutical industry representatives have said.
The two closely related drugs are derived from platinum, a precious metal that has surged in cost due to the Middle East conflict and the closure of the Strait of Hormuz, and form the backbone of treatment for about 60 per cent of advanced cancer cases.
India reports about 1.4 million new cancer cases annually, with an estimated 2.5 to 3 million patients battling the disease at any given time.
Dwindling drug stocks have forced major facilities like All India Institute of Medical Sciences (AIIMS) New Delhi and private hospitals across India to delay or modify treatment schedules, sending patients and families on frantic hunts through pharmacies and distributors.